Gene · 6614
Papers2,964
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,964
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reprogramming the immunosuppressive breast cancer microenvironment: integrating cellular, metabolic, and stromal targets for rational immunotherapy. | Front Immunol | 2026 | 41766877 | PubTator, text mining | PubMed |
Distinct by Design: Unraveling the Unique Clinical and Transcriptomic Identity of Juvenile Scleromyositis Overlap Compared to Juvenile Systemic Sclerosis and Juvenile Dermatomyositis: Implications for Care and Pathogenesis. | ACR Open Rheumatol | 2026 | 41757646 | PubTator, text mining | PubMed |
| CD169+ and HLA-DR+ extracellular vesicles are highly represented in human plasma and dynamically expressed in SARS-CoV-2 infection and long COVID-associated sequelae. | Front Cell Infect Microbiol | 2026 | 41756785 | PubTator, text mining | PubMed |
| Non-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies. | Pharmaceutics | 2026 | 41755006 | PubTator, text mining | PubMed |
| IL-33-Driven Macrophage Reprogramming as a Potential Immunometabolic Strategy for Herpes Simplex Keratitis. | Pharmaceuticals (Basel) | 2026 | 41754825 | PubTator, text mining | PubMed |
| The Fibro-Immune Landscape Across Organs: A Single-Cell Comparative Study of Human Fibrotic Diseases. | Int J Mol Sci | 2026 | 41752153 | PubTator, text mining | PubMed |
| Do Metastatic Cells Arise from PD-L1+ Cell Niches in Gastric Adenocarcinoma? | Int J Mol Sci | 2026 | 41751962 | PubTator, text mining | PubMed |
| Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments. | Int J Mol Sci | 2026 | 41751791 | PubTator, text mining | PubMed |
| Childhood-Onset Systemic Lupus Erythematosus Research over the Past Decade in Japan. | Children (Basel) | 2026 | 41749606 | PubTator, text mining | PubMed |
| Human ISG15 deficiency unveils impaired healing of ulcerations via type I interferon-mediated fibrosis. | J Hum Immun | 2026 | 41743834 | PubTator, text mining | PubMed |
| Nanomedicine Meets Immunotherapy: Transforming Chimeric Antigen Receptor T Cell Treatment for Solid Tumors. | Small Sci | 2026 | 41737839 | PubTator, text mining | PubMed |
| Reprogramming brain-resident macrophages: from disease drivers to therapeutic allies in neurological disorders. | Front Cell Neurosci | 2026 | 41737534 | PubTator, text mining | PubMed |
| Sex-specific association between osteoporosis and cataracts: UK Biobank and Hong Kong Osteoporosis Study. | Arch Osteoporos | 2026 | 41735671 | PubTator, text mining | PubMed |
| Dose-dependent IFN programs in myeloid cells after mRNA and adenovirus COVID-19 vaccination. | JCI Insight | 2026 | 41729080 | PubTator, text mining | PubMed |
| Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic-proteomic-clinical study. | EBioMedicine | 2026 | 41724112 | PubTator, text mining | PubMed |
| SIGLEC-1 expression on monocytes as a diagnostic biomarker in pediatric type I interferon-mediated diseases. | J Allergy Clin Immunol | 2026 | 41720274 | PubTator, text mining | PubMed |
| System biology and network-based approach to identify the therapeutic signatures and potential inhibitors against polycystic lipomembranous osteodysplasia with Sclerosing Leukoencephalopathy. | PLoS One | 2026 | 41719345 | PubTator, text mining | PubMed |
| Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages. | Life Sci Alliance | 2026 | 41714137 | PubTator, text mining | PubMed |
| Current Insights and Future Directions of Multiomic and Spatial-Omic Analysis in Non-Small Cell Lung Cancer. | JCO Precis Oncol | 2026 | 41712875 | PubTator, text mining | PubMed |
| Identification of endometrial CD169+ macrophages essential for Treg cell accumulation and implantation. | Cell Rep | 2026 | 41712382 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6614/papers?page=4